HLRRX
Price
$9.80
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Net Assets
11.65M
VGSLX
Price
$127.04
Change
+$0.67 (+0.53%)
Updated
Aug 15 closing price
Net Assets
63.72B
Interact to see
Advertisement

HLRRX vs VGSLX

Header iconHLRRX vs VGSLX Comparison
Open Charts HLRRX vs VGSLXBanner chart's image
LDR Real Estate Value Opportunity Instl
Price$9.80
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets11.65M
Vanguard Real Estate Index Admiral
Price$127.04
Change+$0.67 (+0.53%)
VolumeN/A
Net Assets63.72B
HLRRX vs VGSLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HLRRX vs. VGSLX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLRRX is a Buy and VGSLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSLX has more cash in the bank: 63.7B vs. HLRRX (11.6M). VGSLX pays higher dividends than HLRRX: VGSLX (3.89) vs HLRRX (2.23). HLRRX was incepted earlier than VGSLX: HLRRX (23 years) vs VGSLX (24 years). HLRRX (2.57) is less costly to investors than VGSLX (0.13). HLRRX is a more actively managed with annual turnover of: 58.24 vs. VGSLX (7.00). VGSLX has a lower initial minimum investment than HLRRX: VGSLX (3000) vs HLRRX (10000). VGSLX annual gain was more profitable for investors over the last year : 1.89 vs. HLRRX (-9.93). VGSLX return over 5 years is better than : 33.64 vs. HLRRX (-2.01).
HLRRXVGSLXHLRRX / VGSLX
Total Expense Ratio2.570.131,977%
Annual Report Gross Expense Ratio2.570.131,977%
Fund Existence23 years24 years-
Gain YTD-8.9902.589-347%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets11.6M63.7B0%
Annual Yield % from dividends2.233.8957%
Returns for 1 year-9.931.89-526%
Returns for 3 years-16.38-0.0917,838%
Returns for 5 years-2.0133.64-6%
Returns for 10 years-29.5556.65-52%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
CRL156.680.88
+0.56%
Charles River Laboratories International
CUB10.500.01
+0.10%
Lionheart Holdings
OACCU10.57N/A
N/A
Oaktree Acquisition Corp III Life Sciences
TRS36.77-0.20
-0.54%
TriMas Corp